Floatz logo

Iloperidone

Iloperidone

Jiangsu Hansoh Pharmaceutical Co., Ltd.Small moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Iloperidone cohort.

Asset / SponsorPhaseRating
Risperdal
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 2B

Same molecule, other indications

Iloperidone is also rated in:

bipolar I disorderDormant
BBB
Indicative ·
73 / 100
View asset →
schizophreniaDormant
BBB
Indicative ·
73 / 100
View asset →
psychotic disorderDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →